Stock Ticker

  • Loading stock data...

Johnson & Johnson (NYSE:JNJ) Promises Enough COVID-19 Vaccine Doses For Americans By Spring

Johnson & Johnson (NYSE:JNJ) is expecting that by April it will have adequate COVID-19 vaccine doses for over 100 million Americans as nationwide vaccination efforts ramp up. JNJ to ramp up vaccine production Dr. Mark McClellan, the company’s board member, and former FDA administrator indicated that JNJ will go all out in the production of […]